Mckesson Medical-Surgical Inc. Corporate Office: Drug Recall
Recall #D-1325-2022 · 06/29/2022
Class II: Risk
Recall Details
- Recall Number
- D-1325-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Mckesson Medical-Surgical Inc. Corporate Office
- Status
- Terminated
- Date Initiated
- 06/29/2022
- Location
- Richmond, VA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23 cartons
Reason for Recall
CGMP Deviations: products were stored outside the drug label specifications.
Product Description
Racepinephrine Inhalation Solution, USP 2.25%, Bronchodilator, For Oral Inhalation Only, Sulfite Free, Preservative Free, 30 x 0.5 mL Sterile Unit-of-Use Vials, each in a foil pouch, per carton, Nephron Pharmaceuticals Corporation, NDC 0487-5901-99.
Distribution Pattern
Nationwide in the USA.
Other Recalls by Mckesson Medical-Surgical Inc. Corporate Office
- Class II: Risk 07/30/2025
- Class II: Risk 04/25/2025
- Class II: Risk 04/25/2025
- Class II: Risk 04/24/2025
- Class II: Risk 04/24/2025
View all recalls by Mckesson Medical-Surgical Inc. Corporate Office →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.